Search News

Corporate Industry Technology Medical Updates

Wuhan Union Hospital

Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Technology
magAssist receives keen international attention at the 47th European Society for Artificial Organs Congress 2021-09-13
Medical Updates
Professor Ping Li "Extra-VAD, could be a greater life-support solution for Bridging to Heart Transplantation" 2021-07-30
Medical Updates
The "Extra-VAD" jointly developed by Wuhan Union Medical College and magAssist Inc. was put into clinical use 2021-07-21
Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference 2021-07-16
Corporate
magAssist's extracorporeal ventricular assist device (Extra-VAD) was presented in the 2021 Suzhou New District Science and Technology Innovation Exhibition 2021-07-12
Technology
The Organ Care System jointly developed by Wuhan Union Hospital and magAssist has ushered in a breakthrough 2021-07-05
Medical Updates
Big country Great Medic｜Nianguo Dong's team, pioneer of heart transplantation in China 2021-06-09
Medical Updates
The Surgical Team of Guangdong Provincial People's Hospital Completed the Preclinical Training on Extracorporeal Ventricular Assist System 2020-12-21
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17

Tabs： heart transfer, acute heart failure, MoyoAssist Extra-VAD, multi-organ failure, LVAD, life support technologies, 30 days life support, extracorporeal artificial hearts, Mechanical Circulatory Support, a fully magnetic levitation blood pump, future healthcare,